Differential expression and signaling of the human histamine H₃ receptor isoforms of 445 and 365 amino acids expressed in human neuroblastoma SH-SY5Y cells

References

• Panula P, Chazot PL, Cowart M, et al. International Union of Basic and Clinical Pharmacology. XCVIII. Histamine receptors. Pharmacol Rev. 2015;67:601–655.
   PubMed Web of Science ®Google Scholar
• Pillot C, Heron A, Cochois V, et al. A detailed mapping of the histamine H(3) receptor and its gene transcripts in rat brain. Neuroscience. 2002;114:173–193.
   PubMed Web of Science ®Google Scholar
• Bongers G, Bakker RA, Leurs R. Molecular aspects of the histamine H3 receptor. Biochem Pharmacol. 2007a;73:1195–1204.
   PubMed Web of Science ®Google Scholar
• Nieto-Alamilla G, Márquez-Gómez R, García-Gálvez AM, et al. The Histamine H3 Receptor: Structure, Pharmacology, and Function. Mol Pharmacol. 2016;90:649–673.
   PubMed Web of Science ®Google Scholar
• Bakker RA. Histamine H3-receptor isoforms. Inflamm Res. 2004;53:509–516.
   PubMed Web of Science ®Google Scholar
• Tardivel-Lacombe J, Morisset S, Gbahou F, et al. Chromosomal mapping and organization of the human histamine H3 receptor gene. Neuroreport. 2001;12:321–324.
   PubMed Web of Science ®Google Scholar
• Cogé F, Gunin SP, Audinot V, et al. Genomic organization and characterization of splice variants of the human histamine H3 receptor. Biochem J. 2001;355:279–288.
   PubMed Web of Science ®Google Scholar
• Wellendorph P, Goodman MW, Burstein ES, et al. Molecular cloning and pharmacology of functionally distinct isoforms of the human histamine H(3) receptor. Neuropharmacology. 2002;42:929–940.
   PubMed Web of Science ®Google Scholar
• Bongers G, Krueger KM, Miller TR, et al. An 80-amino acid deletion in the third intracellular loop of a naturally occurring human histamine H3 isoform confers pharmacological differences and constitutive activity. J Pharmacol Exp Ther. 2007b;323:888–898.
   PubMed Web of Science ®Google Scholar
• Wess J. G-protein-coupled receptors: molecular mechanisms involved in receptor activation and selectivity of G-protein recognition. FASEB J. 1997;11:346–354.
   PubMed Web of Science ®Google Scholar
• Oldham WM, Hamm HE. How do receptors activate G proteins?. Adv Protein Chem. 2007;74:67–93.
   PubMedGoogle Scholar
• Kovalevich J, Langford D. Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology. Methods Mol Biol. 2013;1078:9–21.
   PubMedGoogle Scholar
• Cheng Y, Prusoff WH. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol. 1973;22:3099–3108.
   PubMed Web of Science ®Google Scholar
• Gardner B, Hall DA, Strange PG. Pharmacological analysis of dopamine stimulation of [35S]-GTPγS binding via human D2short and D2long dopamine receptors expressed in recombinant cells. Br J Pharmacol. 1996;118:1544–1550.
   PubMed Web of Science ®Google Scholar
• Flores-Clemente C, Osorio-Espinoza A, Escamilla-Sánchez J, et al. A single-point mutation (Ala280Val) in the third intracellular loop alters the signalling properties of the human histamine H3 receptor stably expressed in CHO-K1 cells. Br J Pharmacol. 2013;170:127–135.
   PubMed Web of Science ®Google Scholar
• Black JW, Leff P. Operational models of pharmacological agonism. Proc R Soc Lond, B, Biol Sci. 1983;220:141–162.
   PubMed Web of Science ®Google Scholar
• Kenakin T, Christopoulos A. Signalling bias in new drug discovery: detection, quantification and therapeutic impact. Nat Rev Drug Discov. 2013;12:205–216.
   PubMed Web of Science ®Google Scholar
• Riddy DM, Cook AE, Diepenhorst NA, et al. Isoform-specific biased agonism of histamine H3 receptor agonists. Mol Pharmacol. 2016;91:87–99.
   PubMed Web of Science ®Google Scholar
• García-Gálvez AM, Escamilla-Sánchez J, Flores-Maldonado C, et al. Differential homologous desensitization of the human histamine H3receptors of 445 and 365 amino acids expressed in CHO-K1 cells. Neurochem Int. 2018;112:114–123.
   PubMed Web of Science ®Google Scholar
• Witte DG, Yao BB, Miller TR, et al. Detection of multiple H3 receptor affinity states utilizing [3H]A-349821, a novel, selective, non-imidazole histamine H3 receptor inverse agonist radioligand. Br J Pharmacol. 2006;148:657–670.
   PubMed Web of Science ®Google Scholar
• Milligan G. Constitutive activity and inverse agonists of G protein-coupled receptors: a current perspective. Mol Pharmacol. 2003;64:1271–1276.
   PubMed Web of Science ®Google Scholar
• Ango F, Prézeau L, Muller T, et al. Agonist-independent activation of metabotropic glutamate receptors by the intracellular protein Homer. Nature. 2001;411:962–965.
   PubMed Web of Science ®Google Scholar
• Takeshita Y, Watanabe T, Sakata T, et al. Histamine modulates high-voltage-activated calcium channels in neurons dissociated from the rat tuberomammillary nucleus. Neuroscience. 1998;87:797–805.
   PubMed Web of Science ®Google Scholar
• Molina-Hernández A, Nuñez A, Sierra JJ, et al. Histamine H3 receptor activation inhibits glutamate release from rat striatal synaptosomes. Neuropharmacology. 2001;41:928–934.
   PubMed Web of Science ®Google Scholar
• Catterall WA. Voltage-gated calcium channels. Cold Spring Harb Perspect Biol. 2011; 3:a003947.
   PubMed Web of Science ®Google Scholar
• De Waard M, Hering J, Weiss N, et al. How do G proteins directly control neuronal Ca2+ channel function?. Trends Pharmacol Sci. 2005;26:427–436.
   PubMed Web of Science ®Google Scholar
• Reuveny E, Narahashi T. Two types of high voltage-activated calcium channels in SH-SY5Y human neuroblastoma cells. Brain Res. 1993;603:64–73.
   PubMed Web of Science ®Google Scholar
• Silver RB, Poonwasi KS, Seyedi N, et al. Decreased intracellular calcium mediates the histamine H3-receptor-induced attenuation of norepinephrine exocytosis from cardiac sympathetic nerve endings. Proc Natl Acad Sci USA. 2002;99:501–506.
   PubMed Web of Science ®Google Scholar
• Seyedi N, Mackins CJ, Machida T, et al. Histamine H3-receptor-induced attenuation of norepinephrine exocytosis: a decreased protein kinase a activity mediates a reduction in intracellular calcium. J Pharmacol Exp Ther. 2005;312:272–280.
   PubMed Web of Science ®Google Scholar
• Bell DC, Butcher AJ, Berrow NS, et al. Biophysical properties, pharmacology, and modulation of human, neuronal L-type (alpha1D, CaV1.3) voltage-dependent calcium currents. J Neurophysiol. 2001;85:816–827.
   PubMed Web of Science ®Google Scholar
• Ivanina T, Blumenstein Y, Shistik E, et al. Modulation of L-type Ca2+ channels by gbeta gamma and calmodulin via interactions with N and C termini of alpha 1C. J Biol Chem. 2000;275:39846–39854.
   PubMed Web of Science ®Google Scholar
• Taussig R, Tang WJ, Hepler JR, et al. Distinct patterns of bidirectional regulation of mammalian adenylyl cyclases. J Biol Chem. 1994;269:6093–6100.
   PubMed Web of Science ®Google Scholar
• Zamponi GW, Snutch TP. Decay of prepulse facilitation of N type calcium channels during G protein inhibition is consistent with binding of a single Gβ subunit. Proc Natl Acad Sci USA. 1998;95:4035–4039.
   PubMed Web of Science ®Google Scholar
• Sahlholm K, Nilsson J, Marcellino D, et al. Voltage sensitivities and deactivation kinetics of histamine H3 and H4 receptors. Biochim Biophys Acta. 2012;1818:3081–3089.
   PubMed Web of Science ®Google Scholar
• Benians A, Leaney JL, Tinker A. Agonist unbinding from receptor dictates the nature of deactivation kinetics of G protein-gated K+ channels. Proc Natl Acad Sci USA. 2003;100:6239–6244.
   PubMed Web of Science ®Google Scholar
• Gbahou F, Rouleau A, Arrang JM. The histamine autoreceptor is a short isoform of the H3 receptor. Br J Pharmacol. 2012;166:1860–1871.
   PubMed Web of Science ®Google Scholar